Comparison of autologous blood prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent temporomandibular joint dislocation on the basis of clinical parameters: A retrospective study

Sandeep Kumar Pandey, Manabendra Baidya, Anurag Srivastava, Himanshu Garg, Sandeep Kumar Pandey, Manabendra Baidya, Anurag Srivastava, Himanshu Garg

Abstract

Introduction: Prolotherapy is a nonsurgical regenerative injection technique and effective treatment method for the treatment of temporomandibular joint (TMJ) dislocation. Autologous blood and dextrose are commonly used agents for prolotherapy and the aim of this study is to compare the autologous blood injection prolotherapy and 25% dextrose prolotherapy for the treatment of chronic recurrent TMJ dislocation.

Method: This is a retrospective cohort study of 20 patients with chronic recurrent TMJ dislocation who were treated by either autologous blood (Group A) or 25% dextrose Prolotherapy (Group B). After prolotherapy, the patients were kept on follow-up and evaluated for maximum mouth opening (MMO), pain at visual analog scale (VAS), mandibular movements, frequency of dislocation, and TMJ sound. The collected data were then statistically analyzed.

Results: Group A showed better results in terms of reduction in MMO, mandibular movements as compared to Group B, and a statistically significant difference was found starting from 2 weeks post prolotherapy till 6 months follow-up. Whereas group B showed better results regarding reduction in pain intensity on VAS Scale at all follow-up visits. No statistically significant difference was found between both groups regarding reduction in the frequency of dislocation and TMJ sounds.

Conclusion: Both autologous and dextrose prolotherapy gives promising results for the treatment of recurrent TMJ dislocation, however, regarding reduction in MMO and improvement in lateral and protrusive mandibular movements, autologous blood gave better results whereas 25% Dextrose was found to be more effective in terms of reduction of pain in recurrent TMJ dislocation cases.

Keywords: MMO; TMJ dislocation; prolotherapy.

Conflict of interest statement

There are no conflicts of interest.

Copyright: © 2022 National Journal of Maxillofacial Surgery.

Figures

Figure 1
Figure 1
Orthopantomogram
Figure 2
Figure 2
TMJ view (open and closed mouth) showing condylar dislocation
Graph 1
Graph 1
Comparison between Group A and Group B according to pain intensity (VAS)
Graph 2
Graph 2
Comparison between Group A and Group B according to frequency of dislocation
Graph 3
Graph 3
Comparison between Group A and Group B according to TMJ Sound

References

    1. Westwood RM, Fox GL, Tilson HB. Eminectomy for the treatment of recurrent temporomandibular joint dislocation. J Oral Surg. 1975;33:774–9.
    1. da Costa Ribeiro R, dos santos BJ, Jr, Provenzano N, de Freitas PH. Dautrey's procedure: An alternative for the treatment of recurrent mandibular dislocation in patients with pneumatization of the articular eminence. Int J Oral Maxillofac Surg. 2014;43:465–9.
    1. Boudreaux RE, Spire ED. Plication of the capsular ligament of the temporomandibular joint: A surgical approach to recurrent dislocation or chronic subluxation. J Oral Surg. 1968;26:330–3.
    1. Maw RB, McKean TW. Scarification of the temporal tendon for treatment of chronic sublaxation of the temporomandibular joint. J Oral Surg. 1973;31:22–5.
    1. Sindet-Pedersen S. Intraoral myotomy of the lateral pterygoid muscle for treatment of recurrent dislocation of the mandibular condyle. J Oral Maxillofac Surg. 1988;46:445–9.
    1. Adekeye EO, Shamia RI, Cove P. Inverted L-shaped ramus osteotomy for prolonged bilateral dislocation of the temporomandibular joint. Oral Surg Oral Med Oral Pathol. 1976;41:568–77.
    1. Daif ET. Autologous blood injection as a new treatment modality for chronic recurrent temporomandibular joint dislocation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:31–6.
    1. Schulz S. Evaluation of periarticular autotransfusion for therapy of recurrent dislocation of the temporomandibular joint. Dtsch Stomatol. 1973;23:94–8.
    1. Jacobi-Hermanns E, Tetsch P. Pericapsular autologous blood injection as therapy for habitual temporomandibular joint luxation. Deutsche Zahnarztliche Zeitschrift. 1981;187:90.
    1. Machon V, Abramowicz S, Paska J, Dolwick MF. Autologous blood injection for the treatment of chronic recurrent temporomandibular joint dislocation. J Oral Maxillofac Surg. 2009;67:114–9.
    1. Hasson O, Nahlieli O. Autologous blood injection for treatment of recurrent temporomandibular joint dislocation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:390–3.
    1. Kato T, Shimoyama T, Nasu D. Autologous blood injection into the articular cavity for the treatment of recurrent temporomandibular joint dislocation: A case report. J Oral Sci. 2007;49:237–41.
    1. Refai H, Altahhan O, Elsharkawy R. The efficacy of dextrose prolotherapy for temporomandibular joint hypermobility: A preliminary prospective, randomized, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg. 2011;69:2962–70.
    1. Cömert Kiliç S, Güngörmüş M. Is dextrose prolotherapy superior to placebo for the treatment of temporomandibular joint hypermobility? A randomized clinical trial. Int J Oral Maxillofac Surg. 2016;45:813–9.
    1. Refai H. Long-term therapeutic effects of dextrose prolotherapy in patients with hypermobility of the temporomandibular joint: A single-arm study with 1-4 years’ follow up. Br J Oral Maxillofac Surg. 2017;55:465–70.
    1. Reeves KD, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000;6:68–74. 77-80.
    1. Topol GA, Reeves KD, Hassanein KM. Efficacy of dextrose prolotherapy in elite male kicking-sport athletes with chronic groin pain. Arch Phys Med Rehabil. 2005;86:697–702.
    1. Rabago D, Zgierska A, Fortney L, Kijowski R, Mundt M, Ryan M, et al. Hypertonic dextrose injections (prolotherapy) for knee osteoarthritis: Results of a single-arm uncontrolled study with 1-year follow-up. J Altern Complement Med. 2012;18:408–14.
    1. Majumdar SK, Krishna S, Chatterjee A, Chakraborty R, Ansari N. Single injection technique prolotherapy for hypermobility disorders of TMJ Using 25% Dextrose: A clinical study. J Maxillofac Oral Surg. 2017;16:226–30.
    1. Zhou H, Hu K, Ding Y. Modified dextrose prolotherapy for recurrent temporomandibular joint dislocation. Br J Oral Maxillofac Surg. 2014;52:63–6.
    1. Brachmann F. Autologous blood injection for recurrent hypermobility of the temporomandibular joint. Dtsch Zahnarztl Z. 1964;15:97–102.
    1. Hegab AF. Treatment of chronic recurrent dislocation of the temporomandibular joint with injection of autologous blood alone, intermaxillary fixation alone, or both together: A prospective, randomised, controlled clinical trial. Br J Oral Maxillofac Surg. 2013;51:813–7.
    1. Triantafillidou K, Venetis G, Markos A. Short-term results of autologous blood injection for treatment of habitual TMJ luxation. J Craniofac Surg. 2012;23:689–92.
    1. Ungor C, Atasoy KT, Taskesen F, Cezairli B, Dayisoylu EH, Tosun E, et al. Short-term results of prolotherapy in the management of temporomandibular joint dislocation. J Craniofac Surg. 2013;24:411–5.
    1. Khamis N, Osman S, Mohamed N. Comparative study between 2 types of prolotherapy in treatment of chronic recurrent temporomandibular joint dislocation. Alexandria Dent J. 2019;44:101–7.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir